デング熱治療の世界市場レポート 2025年

デング熱治療市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR11.6％で36億4,000万米ドルに成長します。予測期間の成長は、万能ワクチンの開発、ワクチン入手の拡大、官民パートナーシップ、遠隔医療の成長、より良いヘルスケア管理のための政策枠組みの強化などに起因すると考えられます。予測期間における主な動向としては、次世代デング熱ワクチンの開発、創薬における人工知能（AI）の利用、スマートコンタクトトレーシングツールの台頭、3Dプリントワクチンの探求、CRISPR技術の標的ウイルス治療への利用などが挙げられます。

デング熱の罹患率の増加は、今後のデング熱治療市場の成長を促進すると予想されます。デング熱は蚊が媒介するウイルス感染症で、インフルエンザのような症状を引き起こし、放置すると重篤な合併症を引き起こす可能性があります。デング熱患者の増加は、都市化、蚊の繁殖を助長する気候変動、不十分な媒介蚊対策、リスクの高い地域での人口増加などの要因によるところが大きいです。タイムリーなデング熱治療は、患者の予後改善と公衆衛生意識の向上を通じて、重篤な症状を緩和し、合併症を予防し、病気の蔓延を抑制することで、罹患率を低下させるのに役立ちます。例えば、2023年に米国疾病予防管理センター（CDC）が発表した報告書によると、南北アメリカにおけるデング熱の患者数は460万人以上に急増し、約4,000人が死亡しました。その結果、デング熱の罹患率の増加がデング熱治療の市場成長を促進すると予想されます。

デング熱治療市場の主要企業は、治療効果を向上させ、疾患の重症度を軽減し、デングウイルスの複数の血清型に同時に対処するために、広域抗ウイルス薬などのイノベーションに注力しています。ブロードスペクトラム抗ウイルス薬は、特定のウイルスを標的とするのではなく、幅広いウイルスに有効な薬です。例えば、2024年9月、韓国の製薬会社であるHyundai Pharmaceutical Co.Ltd.は、COVID-19やデング熱を含む複数のウイルス感染症を治療するために設計された革新的な広域抗ウイルス薬であるXAFTYを発売しました。ザフティは、ニクロサミドの吸収性と有効性を向上させた先進的な製剤を特徴としており、臨床試験において安全性と有効性が実証されているほか、さまざまなRNAウイルスを標的とし、公衆衛生上の緊急事態に直面する地域での迅速な対応能力とともに、将来起こりうる脅威に対する汎用性を備えています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界デング熱治療PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のデング熱治療市場：成長率分析
• 世界のデング熱治療市場の実績：規模と成長, 2019-2024
• 世界のデング熱治療市場の予測：規模と成長, 2024-2029, 2034F
• 世界デング熱治療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のデング熱治療市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ワクチン
• アセトアミノフェン
• 世界のデング熱治療市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 非経口
• オーラル
• 世界のデング熱治療市場薬剤クラス別、実績と予測, 2019-2024, 2024-2029F, 2034F
• NSAIDs
• 抗生物質
• コルチコステロイド
• 世界のデング熱治療市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• オンライン薬局
• 世界のデング熱治療市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 専門クリニック
• 在宅ヘルスケア
• 世界のデング熱治療市場、ワクチンの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 生弱毒化ワクチン
• 組み換えワクチン
• 不活化ワクチン
• 世界のデング熱治療市場アセトアミノフェンの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経口アセトアミノフェン
• 静脈内アセトアミノフェン

第7章 地域別・国別分析

• 世界のデング熱治療市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のデング熱治療市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• デング熱治療市場：競合情勢
• デング熱治療市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Novartis International AG
• GlaxoSmithKline plc
• Takeda Pharmaceutical Company Limited
• Boehringer Ingelheim GmbH
• Hetero Labs Limited
• Sun Pharmaceutical Industries Limited
• Dr. Reddy's Laboratories Limited
• Cipla Incorporated
• Emergent BioSolutions Inc.
• Bharat Biotech International Limited
• Inovio Pharmaceuticals Inc.
• Gennova Biopharmaceuticals Ltd.
• ABIVAX S.A.
• Cadila Healthcare Limited
• Biological E. Limited

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• デング熱治療市場2029：新たな機会を提供する国
• デング熱治療市場2029：新たな機会を提供するセグメント
• デング熱治療市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Dengue treatment involves the medical management and supportive care for individuals infected with the dengue virus, which is transmitted by Aedes mosquitoes. The treatment primarily focuses on supportive care, such as managing fever with paracetamol, providing hydration through oral or intravenous fluids, and closely monitoring for complications such as bleeding or shock to ensure timely intervention and recovery.

The main types of dengue treatment include vaccines and acetaminophen. Vaccines are biological substances that trigger the body's immune system to provide immunity against specific diseases. These vaccines can be administered through various routes, including parenteral and oral. The key drug classes involved in dengue treatment include NSAIDs, antibiotics, and corticosteroids, which are distributed through different channels such as hospital pharmacies, retail pharmacies, and online pharmacies. These treatments are used by a range of end users, including hospitals, specialty clinics, and home healthcare settings.

The dengue treatment market research report is one of a series of new reports from The Business Research Company that provides dengue treatment market statistics, including dengue treatment industry global market size, regional shares, competitors with a dengue treatment market share, detailed dengue treatment market segments, market trends and opportunities, and any further data you may need to thrive in the dengue treatment industry. This dengue treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The dengue treatment market size has grown rapidly in recent years. It will grow from $2.10 billion in 2024 to $2.35 billion in 2025 at a compound annual growth rate (CAGR) of 12.0%. The growth in the historic period can be attributed to several factors, including improvements in diagnostic tools, significant efforts by governments and non-governmental organizations (NGOs), the establishment of epidemiological surveillance systems, substantial investments in research and development (R&D), and community education initiatives aimed at raising awareness and preventing dengue.

The dengue treatment market size is expected to see rapid growth in the next few years. It will grow to $3.64 billion in 2029 at a compound annual growth rate (CAGR) of 11.6%. The growth in the forecast period can be attributed to the development of universal vaccines, an expansion of vaccine availability, public-private partnerships, the growth of telemedicine, and the enhancement of policy frameworks for better healthcare management. Major trends in the forecast period include the development of next-generation dengue vaccines, the use of artificial intelligence (AI) in drug discovery, the rise of smart contact tracing tools, the exploration of 3D-printed vaccines, and the use of CRISPR technology for targeted virus treatments.

The increasing incidence of dengue is anticipated to drive the growth of the dengue treatment market in the future. Dengue is a mosquito-borne viral infection that causes flu-like symptoms and can lead to severe complications if left untreated. The rise in dengue cases is largely attributed to factors such as urbanization, climate change that favors mosquito breeding, insufficient vector control measures, and population growth in high-risk areas. Timely dengue treatment helps reduce the incidence rate by alleviating severe symptoms, preventing complications, and controlling the spread of the disease through improved patient outcomes and enhanced public health awareness. For example, in 2023, a report by the Centers for Disease Control and Prevention (CDC) highlighted that dengue fever cases in the Americas surged to over 4.6 million, with about 4,000 deaths, marking a 13% increase compared to 2022 and a significant rise from previous years. As a result, the increasing incidence of dengue is expected to fuel market growth in dengue treatment.

Key companies in the dengue treatment market are focusing on innovations such as broad-spectrum antiviral drugs to improve treatment efficacy, reduce disease severity, and address multiple serotypes of the dengue virus simultaneously. Broad-spectrum antiviral drugs are medications effective against a wide range of viruses, rather than targeting a specific one. For example, in September 2024, Hyundai Pharmaceutical Co. Ltd., a South Korea-based pharmaceutical company, launched XAFTY, an innovative broad-spectrum antiviral designed to treat multiple viral infections, including COVID-19 and dengue fever. XAFTY features an advanced drug formulation that improves the absorption and effectiveness of niclosamide, has demonstrated safety and efficacy in clinical trials, targets various RNA viruses, and provides versatility against potential future threats, along with the ability for rapid response in regions facing public health emergencies.

In February 2024, Takeda Pharmaceutical Company, a multinational pharmaceutical company based in Japan, collaborated with Biological E. Limited to enhance the production of its dengue vaccine, TAK-003. This partnership aims to increase the annual production of the vaccine to 50 million doses, ensuring sustainable access in dengue-endemic regions and advancing global efforts in dengue prevention. Biological E. Ltd is an India-based biotechnology company specializing in dengue treatment.

Major players in the dengue treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co Inc., Sanofi S.A., Abbott Laboratories, Novartis International AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim GmbH, Hetero Labs Limited, Sun Pharmaceutical Industries Limited, Dr. Reddy's Laboratories Limited, Cipla Incorporated, Emergent BioSolutions Inc., Bharat Biotech International Limited, Inovio Pharmaceuticals Inc., Gennova Biopharmaceuticals Ltd., ABIVAX S.A., Cadila Healthcare Limited, Biological E. Limited

Asia-Pacific was the largest region in the dengue treatment in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in dengue treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the dengue treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The dengue treatment market consists of sales of products including antipyretics, hydration solutions, blood products, nutritional supplements, diagnostic kits, and protective measures. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Dengue Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on dengue treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for dengue treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The dengue treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Vaccines; Acetaminophen
• 2) By Route Of Administration: Parenteral; Oral
• 3) By Drug Class: Nsaids; Antibiotics; Corticosteroids
• 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• 5) By End User: Hospital; Specialty Clinics; Home Healthcare
• Subsegments:
• 1) By Vaccines: Live Attenuated Vaccines; Recombinant Vaccines; Inactivated Vaccines
• 2) By Acetaminophen: Oral Acetaminophen; Intravenous Acetaminophen
• Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche Ltd.; Merck & Co Inc.; Sanofi S.A.; Abbott Laboratories
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Dengue Treatment Market Characteristics

3. Dengue Treatment Market Trends And Strategies

4. Dengue Treatment Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Dengue Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Dengue Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Dengue Treatment Market Growth Rate Analysis
• 5.4. Global Dengue Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Dengue Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Dengue Treatment Total Addressable Market (TAM)

6. Dengue Treatment Market Segmentation

• 6.1. Global Dengue Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Vaccines
• Acetaminophen
• 6.2. Global Dengue Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Parenteral
• Oral
• 6.3. Global Dengue Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Nsaids
• Antibiotics
• Corticosteroids
• 6.4. Global Dengue Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• 6.5. Global Dengue Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital
• Specialty Clinics
• Home Healthcare
• 6.6. Global Dengue Treatment Market, Sub-Segmentation Of Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Live Attenuated Vaccines
• Recombinant Vaccines
• Inactivated Vaccines
• 6.7. Global Dengue Treatment Market, Sub-Segmentation Of Acetaminophen, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Acetaminophen
• Intravenous Acetaminophen

7. Dengue Treatment Market Regional And Country Analysis

• 7.1. Global Dengue Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Dengue Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Dengue Treatment Market

• 8.1. Asia-Pacific Dengue Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Dengue Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Dengue Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Dengue Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Dengue Treatment Market

• 9.1. China Dengue Treatment Market Overview
• 9.2. China Dengue Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Dengue Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Dengue Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Dengue Treatment Market

• 10.1. India Dengue Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Dengue Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Dengue Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Dengue Treatment Market

• 11.1. Japan Dengue Treatment Market Overview
• 11.2. Japan Dengue Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Dengue Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Dengue Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Dengue Treatment Market

• 12.1. Australia Dengue Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Dengue Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Dengue Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Dengue Treatment Market

• 13.1. Indonesia Dengue Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Dengue Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Dengue Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Dengue Treatment Market

• 14.1. South Korea Dengue Treatment Market Overview
• 14.2. South Korea Dengue Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Dengue Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Dengue Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Dengue Treatment Market

• 15.1. Western Europe Dengue Treatment Market Overview
• 15.2. Western Europe Dengue Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Dengue Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Dengue Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Dengue Treatment Market

• 16.1. UK Dengue Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Dengue Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Dengue Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Dengue Treatment Market

• 17.1. Germany Dengue Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Dengue Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Dengue Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Dengue Treatment Market

• 18.1. France Dengue Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Dengue Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Dengue Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Dengue Treatment Market

• 19.1. Italy Dengue Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Dengue Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Dengue Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Dengue Treatment Market

• 20.1. Spain Dengue Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Dengue Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Dengue Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Dengue Treatment Market

• 21.1. Eastern Europe Dengue Treatment Market Overview
• 21.2. Eastern Europe Dengue Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Dengue Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Dengue Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Dengue Treatment Market

• 22.1. Russia Dengue Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Dengue Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Dengue Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Dengue Treatment Market

• 23.1. North America Dengue Treatment Market Overview
• 23.2. North America Dengue Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Dengue Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Dengue Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Dengue Treatment Market

• 24.1. USA Dengue Treatment Market Overview
• 24.2. USA Dengue Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Dengue Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Dengue Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Dengue Treatment Market

• 25.1. Canada Dengue Treatment Market Overview
• 25.2. Canada Dengue Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Dengue Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Dengue Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Dengue Treatment Market

• 26.1. South America Dengue Treatment Market Overview
• 26.2. South America Dengue Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Dengue Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Dengue Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Dengue Treatment Market

• 27.1. Brazil Dengue Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Dengue Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Dengue Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Dengue Treatment Market

• 28.1. Middle East Dengue Treatment Market Overview
• 28.2. Middle East Dengue Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Dengue Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Dengue Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Dengue Treatment Market

• 29.1. Africa Dengue Treatment Market Overview
• 29.2. Africa Dengue Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Dengue Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Dengue Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Dengue Treatment Market Competitive Landscape And Company Profiles

• 30.1. Dengue Treatment Market Competitive Landscape
• 30.2. Dengue Treatment Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

31. Dengue Treatment Market Other Major And Innovative Companies

• 31.1. Novartis International AG
• 31.2. GlaxoSmithKline plc
• 31.3. Takeda Pharmaceutical Company Limited
• 31.4. Boehringer Ingelheim GmbH
• 31.5. Hetero Labs Limited
• 31.6. Sun Pharmaceutical Industries Limited
• 31.7. Dr. Reddy's Laboratories Limited
• 31.8. Cipla Incorporated
• 31.9. Emergent BioSolutions Inc.
• 31.10. Bharat Biotech International Limited
• 31.11. Inovio Pharmaceuticals Inc.
• 31.12. Gennova Biopharmaceuticals Ltd.
• 31.13. ABIVAX S.A.
• 31.14. Cadila Healthcare Limited
• 31.15. Biological E. Limited

32. Global Dengue Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Dengue Treatment Market

34. Recent Developments In The Dengue Treatment Market

35. Dengue Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Dengue Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Dengue Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Dengue Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer